Go to interview with Kathy D Miller, MD
Go to interview with Ms W
Go to interview with Miller MD
Go to interview with Barbara Harkins, RN, MN
Go to interview with Miller MD
Go to interview with Joanne L Blum, MD, PhD
Go to interview with Miller MD
 
 
To listen to individual tracks now, click on the track you wish to listen to.
To download tracks, right-click on the one you wish to download.
 
     
Kathy D Miller, MD
Sheila D Ward Scholar of Medicine
Associate Professor of Medicine
Department of Hematology/Oncology
Indiana University School of Medicine
Indianapolis, Indiana
  
  Click here to download the entire interview  
Track 1 Introduction
Track 2 Role of the oncology nurse at Indiana University
     
  Ms W

  
  Click here to download the entire interview  
Track 1 Introduction
Track 2 Patient interview: A 44-year-old woman with HER2-positive, node-negative breast cancer
Track 3 Dealing with a diagnosis of breast cancer
Track 4 Treatment decisions from the patient’s perspective
Track 5 Patient’s experience with treatment-related side effects
Track 6 Coping with breast cancer
     
Kathy D Miller, MD
Sheila D Ward Scholar of Medicine
Associate Professor of Medicine
Department of Hematology/Oncology
Indiana University School of Medicine
Indianapolis, Indiana

  
  Click here to download the entire interview  
Track 1 Introduction
Track 2 Oncotype DX™: Predictive assay for the use of adjuvant chemotherapy
Track 3 Use of the Oncotype DX assay in clinical practice
Track 4 Selection of adjuvant hormonal therapy
Track 5 Side effects of endocrine therapy
Track 6 Duration of adjuvant endocrine therapy
Track 7 Clinical trial efficacy data with adjuvant trastuzumab
Track 8 Duration and treatment schedule of adjuvant trastuzumab
Track 9 Side effects of adjuvant trastuzumab in combination with chemotherapy
Track 10 Role of delayed adjuvant trastuzumab and trastuzumab monotherapy
     
  Barbara Harkins, RN, MN
Director of Division of Protocol Development
and Management
National Surgical Adjuvant Breast and Bowel Project
Pittsburgh, Pennsylvania
  
  Click here to download the entire interview  
Track 1 Introduction
Track 2 NSABP-B-31: Doxorubicin/cyclophosphamide and paclitaxel with or without trastuzumab in the adjuvant setting
Track 3 Risk of trastuzumab-related cardiotoxicity
Track 4 NSABP-B-31: Efficacy data
Track 5 Impact of the adjuvant trastuzumab data on future clinical trials
Track 6 NSABP-B-40: Clinical trial of neoadjuvant chemotherapy with bevacizumab
Track 7 Potential toxicity risks associated with neoadjuvant bevacizumab
Track 8 NSABP-B-35: Anastrozole versus tamoxifen in the treatment of postmenopausal women with DCIS
Track 9 NSABP-B-42: Letrozole versus placebo in postmenopausal patients who have completed five years of adjuvant endocrine therapy
Track 10 Oncotype DX: Molecular profiling to target use of therapies
Track 11 Role of the nurse in the evolving field of oncology
     
Kathy D Miller, MD
Sheila D Ward Scholar of Medicine
Associate Professor of Medicine
Department of Hematology/Oncology
Indiana University School of Medicine
Indianapolis, Indiana

  
  Click here to download the entire interview  
Track 1 Introduction
Track 2 Establishing goals of therapy with patients in the metastatic setting
Track 3 Selection of endocrine therapy for premenopausal patients with metastatic disease
Track 4 Selection of endocrine therapy for postmenopausal patients with metastatic disease
Track 5 Taxane therapy for the treatment of metastatic disease
Track 6 Side effects of docetaxel versus paclitaxel
Track 7 Nanoparticle albumin-bound (nab) paclitaxel
     
Joanne L Blum, MD, PhD
Director, Hereditary Cancer Risk Program and
Research Site Leader
Baylor-Charles A Sammons Cancer Center
Dallas, Texas
  
  Click here to download the entire interview  
Track 1 Introduction
Track 2 Advantage of avoiding premedication with nab paclitaxel
Track 3 Efficacy and side effects of nab paclitaxel, docetaxel and paclitaxel
Track 4 Discussions with patients faced with a diagnosis of metastatic breast cancer
Track 5 Coping mechanisms of patients faced with metastatic disease
Track 6 Impact of a cancer diagnosis on a patient’s life perspective
     
Kathy D Miller, MD
Sheila D Ward Scholar of Medicine
Associate Professor of Medicine
Department of Hematology/Oncology
Indiana University School of Medicine
Indianapolis, Indiana
  
  Click here to download the entire interview  
Track 1 Introduction
Track 2 Clinical trials of bevacizumab in the treatment of metastatic breast cancer
Track 3 Toxicities associated with bevacizumab
Track 4 Predictors of response to bevacizumab
Track 5 Clinical use of bevacizumab